An international symposium on new developments in neurofibromatoses and rasopathies will be held from 27th  to 29th November 2017 at Crowne Plaza, Kochi (Cochin), Kerala, South India, which will deliberate on their management, diagnosis, current and future therapeutic targets. This is the first international symposium on rasopathies to be held in Asia.

Rasopathies are a class of developmental disorders with overlapping clinical features as well as genetic mutations. RASopathies are associated with dysregulation of the RAS-MAPK (RAS/mitogen activated protein kinase) signalling pathway, an important pathway in humans as it is related to nine different genetic conditions and in many cancers. The meeting will bring together leading scientists, clinicians, researchers and trainee health care professionals in the field of genetics, cancer, neurology, paediatrics, cardiology, neurosurgery, craniofacial surgery, plastic surgery, dermatology, oncology and biomedical sciences from across the world.

This meeting will bring together leading scientists, clinicians, researchers and trainee healthcare professionals in the field of genetics, cancer, neurology, paediatrics, cardiology, neurosurgery, dermatology, oncology and biomedical sciences. This is the first time this international conference is being held in Asia. You will notice from the flyers attached that the organizers have lined up worldwide outstanding speakers for the conference.

Topics covered in the conference are:
•    RASopathies: Syndromes of Ras/ MAPK pathway dysregulation
•    Neurofibromatosis Type 1
•    Legius Syndrome
•    Noonan Syndrome
•    Noonan Syndrome with multiple lentigines
•    Costello Syndrome
•    Cardio-Facio-Cutaneous Syndrome
•    Capillary Malformation-Arteriovenous Malformation Syndrome
•    Natural history, improved diagnosis and
•    genotype phenotype correlation for NF2 and Schwannomatosis
•    New developments in mouse modelling of Neurofibromatoses and RASopathies
•    Translational/Clinical studies in Children and adults with neurofibromatosesand RASopathies